- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The RNA Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global RNA Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Infectious Disease accounting for % of the RNA Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Individualized Cancer Treatment MRNA Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of RNA Vaccines include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, and Sangamo Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
RNA Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Market segment by Application can be divided into
Infectious Disease
Cancer
Other
The key market players for global RNA Vaccines market are listed below:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RNA Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of RNA Vaccines, with price, sales, revenue and global market share of RNA Vaccines from 2019 to 2022.
Chapter 3, the RNA Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and RNA Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Vaccines.
Chapter 13, 14, and 15, to describe RNA Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 RNA Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global RNA Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global RNA Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global RNA Vaccines Market Size & Forecast
1.4.1 Global RNA Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global RNA Vaccines Sales in Volume (2017-2028)
1.4.3 Global RNA Vaccines Price (2017-2028)
1.5 Global RNA Vaccines Production Capacity Analysis
1.5.1 Global RNA Vaccines Total Production Capacity (2017-2028)
1.5.2 Global RNA Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 RNA Vaccines Market Drivers
1.6.2 RNA Vaccines Market Restraints
1.6.3 RNA Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics RNA Vaccines Product and Services
2.1.4 Moderna Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac RNA Vaccines Product and Services
2.2.4 CureVac RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Translate Bio
2.3.1 Translate Bio Details
2.3.2 Translate Bio Major Business
2.3.3 Translate Bio RNA Vaccines Product and Services
2.3.4 Translate Bio RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech RNA Vaccines Product and Services
2.4.4 BioNTech RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics RNA Vaccines Product and Services
2.5.4 Sangamo Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics RNA Vaccines Product and Services
2.6.4 Argos Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art RNA Vaccines Product and Services
2.7.4 In-Cell-Art RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 eTheRNA
2.8.1 eTheRNA Details
2.8.2 eTheRNA Major Business
2.8.3 eTheRNA RNA Vaccines Product and Services
2.8.4 eTheRNA RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris RNA Vaccines Product and Services
2.9.4 Ethris RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology RNA Vaccines Product and Services
2.10.4 Tiba Biotechnology RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 RNA Vaccines Breakdown Data by Manufacturer
3.1 Global RNA Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global RNA Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in RNA Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 RNA Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 RNA Vaccines Manufacturer Market Share in 2021
3.5 Global RNA Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and RNA Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global RNA Vaccines Market Size by Region
4.1.1 Global RNA Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global RNA Vaccines Revenue by Region (2017-2028)
4.2 North America RNA Vaccines Revenue (2017-2028)
4.3 Europe RNA Vaccines Revenue (2017-2028)
4.4 Asia-Pacific RNA Vaccines Revenue (2017-2028)
4.5 South America RNA Vaccines Revenue (2017-2028)
4.6 Middle East and Africa RNA Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global RNA Vaccines Sales in Volume by Type (2017-2028)
5.2 Global RNA Vaccines Revenue by Type (2017-2028)
5.3 Global RNA Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global RNA Vaccines Sales in Volume by Application (2017-2028)
6.2 Global RNA Vaccines Revenue by Application (2017-2028)
6.3 Global RNA Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America RNA Vaccines Sales by Type (2017-2028)
7.2 North America RNA Vaccines Sales by Application (2017-2028)
7.3 North America RNA Vaccines Market Size by Country
7.3.1 North America RNA Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America RNA Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe RNA Vaccines Sales by Type (2017-2028)
8.2 Europe RNA Vaccines Sales by Application (2017-2028)
8.3 Europe RNA Vaccines Market Size by Country
8.3.1 Europe RNA Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe RNA Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific RNA Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific RNA Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific RNA Vaccines Market Size by Region
9.3.1 Asia-Pacific RNA Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific RNA Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America RNA Vaccines Sales by Type (2017-2028)
10.2 South America RNA Vaccines Sales by Application (2017-2028)
10.3 South America RNA Vaccines Market Size by Country
10.3.1 South America RNA Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America RNA Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa RNA Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa RNA Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa RNA Vaccines Market Size by Country
11.3.1 Middle East & Africa RNA Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa RNA Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of RNA Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of RNA Vaccines
12.3 RNA Vaccines Production Process
12.4 RNA Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 RNA Vaccines Typical Distributors
13.3 RNA Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global RNA Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global RNA Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Moderna Therapeutics Major Business
Table 5. Moderna Therapeutics RNA Vaccines Product and Services
Table 6. Moderna Therapeutics RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CureVac Basic Information, Manufacturing Base and Competitors
Table 8. CureVac Major Business
Table 9. CureVac RNA Vaccines Product and Services
Table 10. CureVac RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 12. Translate Bio Major Business
Table 13. Translate Bio RNA Vaccines Product and Services
Table 14. Translate Bio RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. BioNTech Basic Information, Manufacturing Base and Competitors
Table 16. BioNTech Major Business
Table 17. BioNTech RNA Vaccines Product and Services
Table 18. BioNTech RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Sangamo Therapeutics Major Business
Table 21. Sangamo Therapeutics RNA Vaccines Product and Services
Table 22. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Argos Therapeutics Major Business
Table 25. Argos Therapeutics RNA Vaccines Product and Services
Table 26. Argos Therapeutics RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 28. In-Cell-Art Major Business
Table 29. In-Cell-Art RNA Vaccines Product and Services
Table 30. In-Cell-Art RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 32. eTheRNA Major Business
Table 33. eTheRNA RNA Vaccines Product and Services
Table 34. eTheRNA RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Ethris Basic Information, Manufacturing Base and Competitors
Table 36. Ethris Major Business
Table 37. Ethris RNA Vaccines Product and Services
Table 38. Ethris RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 40. Tiba Biotechnology Major Business
Table 41. Tiba Biotechnology RNA Vaccines Product and Services
Table 42. Tiba Biotechnology RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global RNA Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 44. Global RNA Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in RNA Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global RNA Vaccines Production Capacity by Company, (K Doses): 2020 VS 2021
Table 47. Head Office and RNA Vaccines Production Site of Key Manufacturer
Table 48. RNA Vaccines New Entrant and Capacity Expansion Plans
Table 49. RNA Vaccines Mergers & Acquisitions in the Past Five Years
Table 50. Global RNA Vaccines Sales by Region (2017-2022) & (K Doses)
Table 51. Global RNA Vaccines Sales by Region (2023-2028) & (K Doses)
Table 52. Global RNA Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 53. Global RNA Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 54. Global RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 55. Global RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 56. Global RNA Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 57. Global RNA Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 58. Global RNA Vaccines Price by Type (2017-2022) & (USD/Dose)
Table 59. Global RNA Vaccines Price by Type (2023-2028) & (USD/Dose)
Table 60. Global RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 61. Global RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 62. Global RNA Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 63. Global RNA Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 64. Global RNA Vaccines Price by Application (2017-2022) & (USD/Dose)
Table 65. Global RNA Vaccines Price by Application (2023-2028) & (USD/Dose)
Table 66. North America RNA Vaccines Sales by Country (2017-2022) & (K Doses)
Table 67. North America RNA Vaccines Sales by Country (2023-2028) & (K Doses)
Table 68. North America RNA Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 69. North America RNA Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 70. North America RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 71. North America RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 72. North America RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 73. North America RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 74. Europe RNA Vaccines Sales by Country (2017-2022) & (K Doses)
Table 75. Europe RNA Vaccines Sales by Country (2023-2028) & (K Doses)
Table 76. Europe RNA Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe RNA Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 79. Europe RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 80. Europe RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 81. Europe RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 82. Asia-Pacific RNA Vaccines Sales by Region (2017-2022) & (K Doses)
Table 83. Asia-Pacific RNA Vaccines Sales by Region (2023-2028) & (K Doses)
Table 84. Asia-Pacific RNA Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific RNA Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 87. Asia-Pacific RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 88. Asia-Pacific RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 89. Asia-Pacific RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 90. South America RNA Vaccines Sales by Country (2017-2022) & (K Doses)
Table 91. South America RNA Vaccines Sales by Country (2023-2028) & (K Doses)
Table 92. South America RNA Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 93. South America RNA Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 94. South America RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 95. South America RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 96. South America RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 97. South America RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 98. Middle East & Africa RNA Vaccines Sales by Region (2017-2022) & (K Doses)
Table 99. Middle East & Africa RNA Vaccines Sales by Region (2023-2028) & (K Doses)
Table 100. Middle East & Africa RNA Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa RNA Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa RNA Vaccines Sales by Type (2017-2022) & (K Doses)
Table 103. Middle East & Africa RNA Vaccines Sales by Type (2023-2028) & (K Doses)
Table 104. Middle East & Africa RNA Vaccines Sales by Application (2017-2022) & (K Doses)
Table 105. Middle East & Africa RNA Vaccines Sales by Application (2023-2028) & (K Doses)
Table 106. RNA Vaccines Raw Material
Table 107. Key Manufacturers of RNA Vaccines Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. RNA Vaccines Typical Distributors
Table 111. RNA Vaccines Typical Customers
List of Figures
Figure 1. RNA Vaccines Picture
Figure 2. Global RNA Vaccines Revenue Market Share by Type in 2021
Figure 3. Individualized Cancer Treatment MRNA Vaccine
Figure 4. Infectious Disease Treatment MRNA Vaccine
Figure 5. Infection Prevention MRNA Vaccine
Figure 6. Global RNA Vaccines Revenue Market Share by Application in 2021
Figure 7. Infectious Disease
Figure 8. Cancer
Figure 9. Other
Figure 10. Global RNA Vaccines Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 11. Global RNA Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global RNA Vaccines Sales (2017-2028) & (K Doses)
Figure 13. Global RNA Vaccines Price (2017-2028) & (USD/Dose)
Figure 14. Global RNA Vaccines Production Capacity (2017-2028) & (K Doses)
Figure 15. Global RNA Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. RNA Vaccines Market Drivers
Figure 17. RNA Vaccines Market Restraints
Figure 18. RNA Vaccines Market Trends
Figure 19. Global RNA Vaccines Sales Market Share by Manufacturer in 2021
Figure 20. Global RNA Vaccines Revenue Market Share by Manufacturer in 2021
Figure 21. RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 RNA Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 RNA Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 24. Global RNA Vaccines Sales Market Share by Region (2017-2028)
Figure 25. Global RNA Vaccines Revenue Market Share by Region (2017-2028)
Figure 26. North America RNA Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Europe RNA Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific RNA Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. South America RNA Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa RNA Vaccines Revenue (2017-2028) & (USD Million)
Figure 31. Global RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 32. Global RNA Vaccines Revenue Market Share by Type (2017-2028)
Figure 33. Global RNA Vaccines Price by Type (2017-2028) & (USD/Dose)
Figure 34. Global RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 35. Global RNA Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. Global RNA Vaccines Price by Application (2017-2028) & (USD/Dose)
Figure 37. North America RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 38. North America RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 39. North America RNA Vaccines Sales Market Share by Country (2017-2028)
Figure 40. North America RNA Vaccines Revenue Market Share by Country (2017-2028)
Figure 41. United States RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 45. Europe RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 46. Europe RNA Vaccines Sales Market Share by Country (2017-2028)
Figure 47. Europe RNA Vaccines Revenue Market Share by Country (2017-2028)
Figure 48. Germany RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific RNA Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific RNA Vaccines Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific RNA Vaccines Revenue Market Share by Region (2017-2028)
Figure 57. China RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 64. South America RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 65. South America RNA Vaccines Sales Market Share by Country (2017-2028)
Figure 66. South America RNA Vaccines Revenue Market Share by Country (2017-2028)
Figure 67. Brazil RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa RNA Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa RNA Vaccines Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa RNA Vaccines Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa RNA Vaccines Revenue Market Share by Region (2017-2028)
Figure 73. Turkey RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa RNA Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of RNA Vaccines in 2021
Figure 78. Manufacturing Process Analysis of RNA Vaccines
Figure 79. RNA Vaccines Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
